Company News: Pfizer (PFE) Q2 EPS beat analysts’ estimate

Noticias del mercado

1 agosto 2017

Company News: Pfizer (PFE) Q2 EPS beat analysts’ estimate

Pfizer (PFE) reported Q2 FY 2017 earnings of $0.67 per share (versus $0.64 in Q2 FY 2016), beating analysts' consensus estimate of $0.66.

The company's quarterly revenues amounted to $12.896 bln (-1.9% y/y), missing analysts' consensus estimate of $13.077 bln.

The company also raised its FY 2017 EPS forecast to $2.54-2.60 from $2.50-2.60 (versus analysts' consensus estimate of $2.55) and reaffirmed FY 2017 revenues guidance at $52-54 bln (versus analysts' consensus estimate of $52.78 bln).

PFE rose to $33.20 (+0.12%) in pre-market trading.

U.S.: Personal Income, m/m, June 0% (forecast 0.4%)

Eurozone GDP growth accelerates slightly in Q2

Enfoque del mercado

Material posted here is solely for information purposes and reliance on this may lead to losses. Past performances are not a reliable indicator of future results. Please read our full disclaimer

Abrir cuenta demo y página personal

Área personal

support@teletradepartners.com

Aviso de riesgo: El hecho de realizar operaciones comerciales en los mercados financieros con instrumentos financieros de margen abre grandes oportunidades y permite a los inversores que estén dispuestos a correr riesgos a obtener altos rendimientos, pero al mismo tiempo conlleva un nivel de riesgo de pérdidas potencialmente alto. Por lo tanto, antes de comenzar a operar, se debe tomar de manera responsable a la cuestión de elegir una estrategia de inversión correspondiente, teniendo en cuenta los recursos disponibles.

Política de privacidad